TLX insider trading — Telix Pharmaceuticals Ltd
Over the last 90 days, insiders at Telix Pharmaceuticals Ltd (TLX) made 1 open-market purchase worth $20K and 0 open-market sales worth $0, making them net buyers by $20K. The largest purchase was by Smith Darren Charlton (Group Chief Financial Officer), who bought 2,071 shares for $20K on Sep 7, 2026.
Updated Oct 16, 2026.
Recent TLX insider transactions
Every Form 4 filed by Telix Pharmaceuticals Ltd officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2026 | Smith Darren Charlton | Group Chief Financial Officer | P · Purchase | Direct | 2,071 | $9.66 | $20K | Form 4 |
TLX insider trading FAQ
Are insiders buying TLX stock?
Yes. In the last 90 days, Telix Pharmaceuticals Ltd insiders made 1 open-market purchase totaling $20K, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading TLX?
Recent buyers: Smith Darren Charlton.
Where does TLX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.